While research is ongoing, there are scientists that believe CBD can help treat a wide variety of ailments. One of the reasons it’s being examined as a therapeutic agent is that it doesn’t appear to have any side effects.
According to Nora D. Volkow, director of the National Institute on Drug Abuse Senate Caucus on International Narcotics Control, “Pre-clinical research (including both cell culture and animal models) has shown CBD to have a range of effects that may be therapeutically useful, including anti-seizure, antioxidant, neuroprotective, anti-inflammatory, analgesic, anti-tumor, anti-psychotic, and anti-anxiety properties.”
The British Pharmacology Society claims that CBD is, “a potential medicine for the treatment of neuroinflammation, epilepsy, oxidative injury, vomiting and nausea, anxiety and schizophrenia, respectively. The neuroprotective potential of CBD, based on the combination of its anti-inflammatory and anti-oxidant properties, is of particular interest and is presently under intense preclinical research in numerous neurodegenerative disorders.”
A recent search on the US National Library of Medicine National Institutes of Health shows more than 1,500 published studies on the benefits and effects of CBD. The substance is being researched to treat post-traumatic stress disorder (PTSD), various types of cancer, drug addiction, fibromyalgia, depression, and more.
While pharmaceutical companies, particularly GW Pharmaceutical, have successfully used cannabidiol in various medicines, companies that have products in health food stores or vape shops are in a trickier position. Many will espouse the health benefits of CBD in a private setting, while being reluctant to make public claims due to fear of the US Food & Drug Administration (FDA).